Holen Sie sich die Stockscreener-App
17.04
5.25%
0.85
Schlusskurs vom Vortag:
$16.19
Offen:
$16.4
24-Stunden-Volumen:
2.95M
Relative Volume:
1.36
Marktkapitalisierung:
$1.47B
Einnahmen:
$139.71M
Nettoeinkommen (Verlust:
$-209.36M
KGV:
-5.7568
EPS:
-2.96
Netto-Cashflow:
$-160.60M
1W Leistung:
+4.35%
1M Leistung:
+35.56%
6M Leistung:
+17.68%
1J Leistung:
-13.06%
1-Tages-Spanne:
$16.29
$17.23
1-Wochen-Bereich:
$15.81
$17.23
52-Wochen-Spanne:
$8.58
$22.50
Syndax Pharmaceuticals Inc Stock (SNDX) Company Profile
Firmenname
Syndax Pharmaceuticals Inc
Sektor
Branche
Telefon
781-419-1400
Adresse
730 THIRD AVENUE, NEW YORK, MA
Vergleichen Sie SNDX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SNDX
Syndax Pharmaceuticals Inc
|
17.04 | 1.39B | 139.71M | -209.36M | -160.60M | -2.96 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Syndax Pharmaceuticals Inc Stock (SNDX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-04 | Fortgesetzt | Guggenheim | Buy |
| 2025-08-05 | Bestätigt | BTIG Research | Buy |
| 2025-07-10 | Eingeleitet | Goldman | Buy |
| 2024-10-24 | Eingeleitet | UBS | Buy |
| 2024-06-28 | Eingeleitet | Jefferies | Buy |
| 2024-01-31 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2023-12-22 | Eingeleitet | Mizuho | Buy |
| 2023-10-25 | Eingeleitet | BofA Securities | Buy |
| 2023-10-11 | Eingeleitet | Goldman | Buy |
| 2023-07-27 | Eingeleitet | Scotiabank | Sector Outperform |
| 2023-07-11 | Eingeleitet | Guggenheim | Buy |
| 2023-04-17 | Fortgesetzt | BTIG Research | Buy |
| 2023-01-31 | Eingeleitet | Stifel | Buy |
| 2023-01-03 | Eingeleitet | JP Morgan | Overweight |
| 2022-07-28 | Fortgesetzt | B. Riley Securities | Buy |
| 2022-04-11 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-02-15 | Eingeleitet | Goldman | Buy |
| 2021-06-04 | Fortgesetzt | Robert W. Baird | Outperform |
| 2021-05-25 | Eingeleitet | Citigroup | Buy |
| 2021-02-18 | Eingeleitet | B. Riley Securities | Buy |
| 2020-12-03 | Eingeleitet | Stifel | Buy |
| 2020-05-22 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-05-22 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2020-05-18 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-05-11 | Bestätigt | H.C. Wainwright | Buy |
| 2020-03-04 | Eingeleitet | Barclays | Overweight |
| 2020-01-13 | Bestätigt | H.C. Wainwright | Buy |
| 2019-03-08 | Bestätigt | H.C. Wainwright | Buy |
| 2019-01-04 | Eingeleitet | Robert W. Baird | Outperform |
| 2018-01-05 | Eingeleitet | B. Riley FBR, Inc. | Buy |
| 2017-03-16 | Eingeleitet | FBR & Co. | Outperform |
| 2017-03-02 | Eingeleitet | Instinet | Buy |
| 2016-10-07 | Eingeleitet | Guggenheim | Buy |
| 2016-03-28 | Eingeleitet | Citigroup | Buy |
| 2016-03-28 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2016-03-28 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Syndax Pharmaceuticals Inc Aktie (SNDX) Neueste Nachrichten
When Will Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Turn A Profit? - simplywall.st
Trexquant Investment LP Decreases Stock Position in Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat
Point72 Europe London LLP Acquires Shares of 184,683 Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat
Wellington Management Group LLP Sells 4,198,493 Shares of Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat
Why is Syndax Pharmaceuticals Inc. stock going downEarnings Growth Summary & Weekly Stock Performance Updates - خودرو بانک
Syndax Pharmaceuticals (NASDAQ:SNDX) Coverage Initiated at Guggenheim - MarketBeat
How does Syndax Pharmaceuticals Inc. perform in inflationary periodsJuly 2025 Levels & Real-Time Stock Price Movement Reports - خودرو بانک
What chart patterns are forming on Syndax Pharmaceuticals Inc.July 2025 Selloffs & Entry Point Confirmation Signals - خودرو بانک
Does Syndax Pharmaceuticals Inc. meet Warren Buffett’s criteriaJuly 2025 News Drivers & Technical Buy Zone Confirmation - خودرو بانک
Can Syndax Pharmaceuticals Inc. deliver consistent dividendsJuly 2025 Recap & Fast Moving Market Watchlists - خودرو بانک
Is Syndax Pharmaceuticals Inc. stock a value trapMarket Trend Report & Risk Controlled Daily Plans - خودرو بانک
Invesco Ltd. Has $944,000 Stock Holdings in Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat
Syndax Pharmaceuticals reports inducement grants under Nasdaq Listing Rule 5635(c)(4) - MarketScreener
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | SNDX Stock News - GuruFocus
Syndax Pharmaceuticals' Strategic Use of Inducement Grants to Fuel Long-Term Growth - AInvest
What’s the profit margin of Syndax Pharmaceuticals Inc.2025 EndofYear Setup & Short-Term High Return Strategies - خودرو بانک
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - GlobeNewswire
Is Syndax Pharmaceuticals Inc. forming a double bottomQuarterly Profit Report & Stepwise Swing Trade Plans - خودرو بانک
Signal strength of Syndax Pharmaceuticals Inc. stock in tech scannersJuly 2025 Decliners & Weekly High Potential Stock Alerts - Newser
Is a relief rally coming for Syndax Pharmaceuticals Inc. holdersInsider Buying & Real-Time Stock Price Movement Reports - Newser
Should I trade or invest in Syndax Pharmaceuticals Inc.July 2025 Short Interest & Weekly High Return Stock Opportunities - خودرو بانک
Goldman Sachs Raises Price Target on Syndax Pharmaceuticals (SND - GuruFocus
Does Syndax Pharmaceuticals Inc. have consistent dividend growthJuly 2025 Technicals & Risk Adjusted Swing Trade Ideas - خودرو بانک
Can a trend reversal in Syndax Pharmaceuticals Inc. lead to recoveryJuly 2025 Levels & Real-Time Stock Movement Alerts - Newser
Will Syndax Pharmaceuticals Inc. benefit from macro trendsEarnings Miss & Community Verified Trade Signals - Newser
Syndax Pharmaceuticals, Inc. $SNDX Shares Bought by Palo Alto Investors LP - MarketBeat
Ieq Capital LLC Invests $727,000 in Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat
Will Syndax Pharmaceuticals Inc. continue its uptrendWeekly Trade Report & Weekly Sector Rotation Insights - Newser
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Given Average Recommendation of "Buy" by Analysts - MarketBeat
Will Syndax Pharmaceuticals Inc. benefit from green energy policiesMarket Movers & Expert Approved Trade Ideas - خودرو بانک
Guggenheim initiates Syndax Pharmaceuticals stock with Buy rating on AML drug success - Investing.com Canada
Understanding Syndax Pharmaceuticals Inc.’s price movementWeekly Trend Summary & Smart Money Movement Alerts - Newser
Syndax Pharmaceuticals Inc. (SNDX) Gains Attention with Promising Drug Portfolio and Narrower-than-Expected Q2 Loss - AInvest
Syndax Gains Attention With Strong Drug Portfolio, Path To Leukemia Market Growth - Benzinga
Is this a good reentry point in Syndax Pharmaceuticals Inc.2025 Investor Takeaways & Risk Managed Trade Strategies - Newser
Nuveen LLC Acquires Shares of 224,153 Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat
Real time breakdown of Syndax Pharmaceuticals Inc. stock performanceGlobal Markets & Long-Term Safe Investment Plans - Newser
Predicting Syndax Pharmaceuticals Inc. trend using moving averagesJuly 2025 Selloffs & Free Real-Time Volume Trigger Notifications - Newser
What are the future prospects of Syndax Pharmaceuticals Inc.2025 Trading Recap & Daily Oversold Stock Bounce Ideas - خودرو بانک
Can trapped investors hope for a rebound in Syndax Pharmaceuticals Inc.Quarterly Profit Summary & Long-Term Capital Growth Ideas - Newser
Tema Etfs LLC Buys Shares of 21,169 Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat
How high can Syndax Pharmaceuticals Inc. stock price go in 2025Market Growth Review & Consistent Profit Trading Strategies - Newser
Syndax Pharmaceuticals Inc. recovery potential after sell offEarnings Growth Report & Trade Opportunity Analysis Reports - Newser
Russell Investments Group Ltd. Has $1.45 Million Stock Holdings in Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat
Statistical indicators supporting Syndax Pharmaceuticals Inc.’s strengthProfit Target & Accurate Intraday Trading Signals - Newser
Smart tools for monitoring Syndax Pharmaceuticals Inc.’s price actionPortfolio Return Report & Precise Trade Entry Recommendations - Newser
Intraday pattern recognizer results for Syndax Pharmaceuticals IncPrice Action & Real-Time Volume Trigger Notifications - Newser
Syndax Pharmaceuticals' Strategic Position in the Evolving Oncology Landscape - AInvest
Finanzdaten der Syndax Pharmaceuticals Inc-Aktie (SNDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Syndax Pharmaceuticals Inc-Aktie (SNDX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Podlesak Dennis | Director |
Aug 15 '25 |
Option Exercise |
7.20 |
19,200 |
138,240 |
210,963 |
| Podlesak Dennis | Director |
Aug 18 '25 |
Option Exercise |
7.20 |
19,200 |
138,240 |
210,963 |
| Podlesak Dennis | Director |
Aug 18 '25 |
Sale |
15.84 |
19,200 |
304,170 |
191,763 |
| Podlesak Dennis | Director |
Aug 15 '25 |
Sale |
15.54 |
19,200 |
298,408 |
191,763 |
| Podlesak Dennis | Director |
Aug 14 '25 |
Sale |
14.19 |
19,200 |
272,521 |
191,763 |
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):